Quantification of epidermal growth factor receptor T790M mutant transcripts in lung cancer cells by real-time reverse transcriptase-quantitative polymerase chain reaction

Anal Biochem. 2010 Mar 15;398(2):266-8. doi: 10.1016/j.ab.2009.11.034. Epub 2009 Dec 2.

Abstract

A simple and sensitive real-time reverse transcriptase-quantitative polymerase chain reaction (RT-qPCR) was developed to quantify threonine-to-methionine substitution at amino acid position 790 (T790M) mutant transcripts in a wild-type (wt) epidermal growth factor receptor background. The assay is based on three unmodified oligonucleotides, and both SYBR Green and a Taqman probe can be used. To increase the discrimination between mutant and wt signals, ARMS (amplification refractory mutation system) and LNA (locked nucleic acid) primers were tested, but a benefit was observed only with plasmids and not with cellular complementary DNA. The RT-qPCR assay using transcript-specific primers can detect as few as 1% T790M transcripts in a wt background and, therefore, will be useful in RNA interference studies specifically targeting mutant RNA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • Cell Line, Tumor
  • DNA, Complementary / genetics
  • ErbB Receptors / genetics*
  • Humans
  • Lung Neoplasms / pathology*
  • Mutation*
  • RNA, Messenger / genetics
  • Reverse Transcriptase Polymerase Chain Reaction*
  • Time Factors

Substances

  • DNA, Complementary
  • RNA, Messenger
  • ErbB Receptors